SCHEMBL23698296

SCHEMBL23698296

O=C(N/N=C\c1ccc(Cl)c([N+](=O)[O-])c1)c1ccco1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
HTT P42858 2/20 0.62
NPC1 O15118 7/20 0.60
ALDH1A1 P00352 6/20 0.60
NPSR1 Q6W5P4 3/20 0.60
POLB P06746 2/20 0.60
LMNA P02545 1/20 0.60
DUSP3 P51452 1/20 0.59
PTPN5 P54829 1/20 0.59
PTPN11 Q06124 1/20 0.59
CTDSP1 Q9GZU7 1/20 0.59
RAB9A P51151 6/20 0.57
PKM P14618 3/20 0.56
KDM4E B2RXH2 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
NFKB1 P19838 1/20 0.54
GFER P55789 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23698297 1.00 MAPT (0.67) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL23698307 0.85 MAPT (0.67) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL21887104 0.85 MAPT (0.67) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL8291982 0.81 MAPT (0.66) MAPTMEN1KMT2AHTTNPC1
SCHEMBL10905633 0.80 MAPT (0.71) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL16035566 0.76 DUSP3 (0.69) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL12858673 0.76 DUSP3 (0.69) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL16035565 0.76 DUSP3 (0.69) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL23698299 0.76 ALDH1A1 (0.60) MAPTL3MBTL1MEN1KMT2AHTT
SCHEMBL23698298 0.76 ALDH1A1 (0.60) MAPTL3MBTL1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858342-A1 ACYLHYDRAZONES FOR THE TREATMENT OF NEUROLOGICAL DISEASES Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2021-08-04 EP claimed
EP-3858342-A1 ACYLHYDRAZONES FOR THE TREATMENT OF NEUROLOGICAL DISEASES Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2021-08-04 EP disclosed